Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The EBAG9 pseudogene 1 (EBAG9P1) is a non-functional genomic sequence related to the EBAG9 gene, which encodes a membrane-associated antigen known for being estrogen-inducible and involved in the regulation of exocytosis, immune response modulation, and cancer pathophysiology. As a pseudogene, EBAG9P1 does not code for a functional protein and is not itself considered a therapeutic target or of known biological or pathological significance[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EBAG9 pseudogene 1 (EBAG9P1).